PBMC-engrafted humanized mice models for evaluating immune-related and anticancer drug delivery systems

Area of Science:

• Oncology
• Immunology
• Biomedical Engineering

Background:

• Immune-related drug delivery systems (DDSs) are crucial for bridging preclinical cancer research and clinical applications.
• Humanized mouse models provide platforms for studying drug interactions with human immune systems.
• Understanding immune responses is key to developing effective cancer therapies.

Purpose of the Study:

• To introduce a novel dual-function DDS with anticancer and immune-modulating capabilities.
• To present a peripheral blood mononuclear cell (PBMC)-engrafted humanized mouse model for evaluating multifunctional DDSs.
• To discuss challenges and applications for advancing DDSs in cancer treatment.

Main Methods:

• Development of a unique DDS with dual anticancer and immune-tuning functions.
• Establishment of a PBL-NOG-hIL-4-Tg humanized mouse model for rapid immune reconstruction.
• Evaluation of the DDS and model system for cancer therapy research.

Main Results:

• The developed DDS exhibits both direct anticancer effects and the ability to fine-tune immune reactions.
• The PBL-NOG-hIL-4-Tg mouse model facilitates rapid engraftment of individual donor immunity.
• This model system avoids graft-versus-host disease, enhancing its utility for DDS development.

Conclusions:

• The novel DDS and humanized mouse model represent significant advancements in cancer therapy research.
• This integrated system offers a superior platform for developing multifunctional DDSs.
• Further development holds promise for improved cancer treatment strategies based on immune response modulation.